Washington University School Of Medicine - Latest News Update, Information, Photos & Videos on Washington University School Of Medicine at Lokmat Times

According to the study published in the journal Nature, the researchers found that boosting the activity of such cells could help reduce the millions of new infections that occur worldwide every year.For the study, the researchers from Washington University School of Medicine and Africa Health Research Institute carried out research on animals and people to identify the immune cells that defend the body against the TB bacteria in the first days after infection.They found that cells known as group 3 innate lymphoid cells (ILC3) play a pivotal role in the first two weeks of infection. ILC3 cells belong to the innate branch of the immune system that detects and responds to foreign invaders in the body."The immune response to the TB bacteria hinges on the early response of this cell, and that opens up a whole new avenue for TB control," said the study's co-senior author Shabaana Abdul Khader, Professor at Washington University School of Medicine, US.Experiments showed that within five days after infection, ILC3 cells show up in the lungs, where they release chemical compounds that activate and attract other immune cells. The arriving cells include other innate immune cells - which come loaded with bacteria-killing weapons - as well as adaptive immune cells that direct and enhance the innate immune cells' killing potential. Together, the immune cells surround the bacteria and destroy them."These innate lymphoid cells seem to orchestrate all the early downstream immune responses, both innate and adaptive, that you need to control infection," noted Khader.The researchers have begun screening a set of chemical compounds, looking for ones that enhance ILC3 activity and drive a stronger immune response in the first day after infection."The more we can understand about the interaction between the bacteria that cause TB and people, the more chance we have of building on these gains and defeating this deadly epidemic," said the study's co-senior author Alasdair Leslie, a faculty member from Africa Health Research Institute, South Africa.The researchers maintained that they wouldn't want to replace the BCG vaccine."We may be able to find a compound that we can use to boost immunity in vaccinated children when the effects of the BCG start to wear off," Khader said.According to the World Health Organization (WHO), about 1.5 million people died of TB in 2017, making it the most lethal infectious disease worldwide.( With inputs from IANS )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Operation Sindoor

Pahalgam Terror Attack

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Washington University School Of MedicineFOLLOW

Washington university school of medicine, Latest News

Technology :Study: Environmental allergens linked to acute itching in eczema patients

A new research has indicated that itching often doesn't respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don't target. ...

Health :Rapid blood test identifies COVID-19 patients at high risk of severe disease: Study

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict -- within a day of a hospital admission -- which patients with COVID-19 are at highest risk of severe complicatio ...

Health :Acute itching in eczema patients linked to environmental allergens

New research from Washington University School of Medicine in St. Louis indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients. ...

Business :Natco donates Chloroquine for international study to prevent SARS-CoV-2 infection

Natco Pharma Ltd said on Tuesday it has donated Chloroquine phosphate tablets through its marketing partner in the United States Rising Pharmaceuticals to support a global clinical trial conducted by the CROWN Collaborative for protecting essential h ...

Health :High-protein diets clog arteries, up heart disease risk

High-protein diets may help people lose weight and build muscle, but there is a downside to it a" a greater heart attack risk. Researchers now report that high-protein diets boost artery-clogging plaque. ...

Health :Master cell playing key role in fighting TB identified

Researchers have identified a master cell that coordinates the body's immune response in the early days of TB infection. ...